EX-99.1 2 a06-6877_1ex99d1.htm EXHIBIT 99

Exhibit 99.1

 

NEWS RELEASE

 

 

Contact:

Connie Chandler

 

Investor Relations

 

Tele: 714-573-1115

 

Email: ir@srslabs.com

 

 SRS LABS REPORTS LICENSING REVENUE FOR
FISCAL 2005 GREW 37 PERCENT DURING THE YEAR
AND 59 PERCENT IN THE FOURTH QUARTER
 

Santa Ana, Calif., March 14, 2006—SRS Labs (NASDAQ: SRSL), a leading provider of innovative audio and voice technology solutions, announced today that licensing revenue for the twelve-month period ended December 31, 2005 grew 37 percent to $14.8 million from $10.8 million in fiscal 2004. This growth was driven by the company’s success in accessing more broadly its five target market segments which resulted in increased sales in such product categories as portable audio devices, mobile phones and PCs, as well as continued demand in the home theater market. Revenues from the licensing business in the fourth quarter of 2005 increased 59 percent to $4.3 million from $2.7 million in the same period in 2004.

 

Consolidated net sales for the fiscal year ended December 31, 2005, including the company’s Hong Kong-based semiconductor business, increased by 7.5 percent to $23.2 million from $21.6 million for fiscal 2004. On March 1, 2006, SRS announced that it intends to sell its semiconductor business to focus increased management attention and resources on what it believes to be a large and expanding market for its core licensing business. As a result, beginning with the first quarter ending March 31, 2006, SRS will account for the semiconductor business segment as a discontinued operation.

 

The company reported a net loss of $1.4 million, or ($0.10) per diluted share for fiscal 2005, compared to net income of $1.6 million, or $.10 per diluted share, for the prior year. The loss in 2005 was primarily due to a non-cash and nonrecurring after-tax impairment charge of $3.3 million, which was announced on March 1, 2006, related to the company’s investment in a joint venture alliance with Coming Home Studios.

 

SRS Labs, Inc. 2909 Daimler Street, Santa Ana, CA  92705    Tel 949-442-1070    Fax 949-852-1099   www.srslabs.com

 



 

Gross margins in 2005 for SRS Labs’ consolidated business were 72 percent compared to 82 percent in 2004. This decline was attributable primarily to the company’s decision to record an asset impairment charge associated with its joint venture with Coming Home Studios. Gross margins in the licensing segment of the business were 78 percent. Excluding the asset impairment charge related to Coming Home Studios, the gross margins for the licensing business were 97 percent for 2005. Management believes that referencing both gross margins in the licensing business provides important perspective related to the operating performance of the business going forward. Consolidated operating expenses increased from $15.9 million in 2004 to $18.0 million in 2005 due to increased sales and marketing headcount, commissions on increased licensing revenues, and increased professional fees and public company expenses.

 

According to SRS Labs’ chairman and chief executive officer, Thomas C. K. Yuen, “We are pleased to have achieved such strong and steady growth in our core licensing business throughout 2005, and we believe we are well positioned to continue to build on this strength in 2006. Our innovative audio and voice technology is well-suited to the unique design requirements of today’s thinner, more compact and miniaturized electronic products and offers a solution which enables a high-quality listening experience for consumers.

 

“We believe our technology provides a way for manufacturers of such products as flat panel TVs, cell phones, MP3 and DVD players as well as laptop computers and car audio systems, to deliver a noticeably improved sound quality and as a result differentiate their devices in the market. For example, using our technology, electronics manufacturers of portable media players have a cost-effective, quick-to-market means for recapturing some of the sound quality lost when music is compressed into digital files. And for the mobile phones games market, our XSPACE 3D™ generates a vivid, life-like audio environment achieved with the precise placement of sound as well as multi-dimensional sound movement.

 

“As we go forward, our new team of senior executives is committed to focusing on expanding our market opportunities with both consumer electronics manufacturers and chip manufacturers/platform partners, while our highly expert audio technologists and scientists expect to continue to expand our portfolio of innovative audio and voice technology,” Yuen said.

 

2



 

Conference Call

 

SRS will host a conference call and webcast at 2 p.m. Pacific Time today (5 p.m. Eastern Time) to review its 2005 year-end and fourth quarter results. The dial-in number for the call in North America is 866-259-6033 and
703-639-1219 for international callers. The call will also be webcast live over the Internet. Simply log-on to www.srslabs.com.

 

The web cast will be archived on the company’s website for 60 days following the call. An audio replay of the conference call will be available for seven days beginning at 5 p.m. Pacific Time on March 14. The audio replay dial-in number for North American is 866-837-8032 and 703-925-2474 for international callers. The replay pass code is 867016.

 

About SRS Labs, Inc.

 

SRS Labs is a recognized leader in the advancement of audio and voice technology. The company works with the world’s top manufacturers to provide a richer entertainment experience through patented sound techniques. SRS Labs’ technologies can be heard through products ranging from televisions, LCD and plasma monitors, cell phones, MP3 players, car audio systems, and notebook and desktop computers. The company also offers hardware and software tools to professionals and consumers for the creation, production and broadcast of content featuring SRS Labs’ technologies. Valence Technology Limited, a Hong-Kong based subsidiary of SRS Labs, is a semiconductor company that designs and sells custom ASICs and standard ICs to leading manufacturers worldwide. Based in Santa Ana, Calif., the company also has licensing representation in Hong Kong, Japan, Europe, and Korea. For more information about SRS Labs, Inc. please visit www.srslabs.com. The information on the aforementioned website is not incorporated by reference into this press release.

 

Except for historical information contained in this release, statements in this release, including those of Mr. Yuen are forward-looking statements and projections (which include statements concerning plans and objectives of management for future operations) that are based on management’s belief, as well as assumptions made by, and information currently available to, management. While the company believes that its expectations are based upon reasonable assumptions, there can be no assurances that the company’s goals and strategy will be realized. Numerous factors, including risks and uncertainties, may affect the company’s actual results and may cause results to differ materially from those expressed in forward-looking statements made by or on behalf of the company. Some of these factors include uncertainties related to the sale of Valence Technology Limited and the divestiture of the company’s equity investment in the joint venture, the general market conditions concerning the semiconductor business, the acceptance of new SRS Labs’ products and technologies, the impact of competitive products and pricing, the timely development and release of technologies by the company, general business and economic conditions, especially in Asia, and other factors detailed in the company’s Form 10-K and other periodic reports filed with the SEC. SRS Labs specifically disclaims any obligation to update or revise any forward-looking statement whether as a result of new information, future developments or otherwise.

 

(Summary Financial Information Follows)

 

3



 

SRS LABS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

Years Ended December 31,

 

 

 

2005

 

2004

 

2003

 

Revenue:

 

 

 

 

 

 

 

Licensing

 

$

14,795,810

 

$

10,831,704

 

$

9,101,399

 

Semiconductor

 

8,432,449

 

10,770,684

 

10,712,382

 

Total revenues

 

23,228,259

 

21,602,388

 

19,813,781

 

 

 

 

 

 

 

 

 

Cost of sales:

 

 

 

 

 

 

 

Licensing

 

446,849

 

228,147

 

102,979

 

Write-off of capitalized production costs

 

2,757,172

 

 

 

Semiconductor

 

3,411,649

 

3,725,062

 

3,953,100

 

Total cost of sales

 

6,615,670

 

3,953,209

 

4,056,079

 

Gross margin

 

16,612,589

 

17,649,179

 

15,757,702

 

Operating expenses

 

 

 

 

 

 

 

Sales and marketing

 

6,890,666

 

5,445,224

 

5,487,159

 

Research and development

 

4,700,016

 

4,767,004

 

4,263,682

 

General and administrative

 

6,401,021

 

5,675,294

 

5,053,387

 

Total operating expenses

 

17,991,703

 

15,887,522

 

14,804,228

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

(1,379,114

)

1,761,657

 

953,474

 

 

 

 

 

 

 

 

 

Write-off of investment

 

(185,304

)

 

 

 

 

 

 

 

 

 

 

Equity in income of investee

 

91,096

 

32,358

 

 

Other income, net

 

669,830

 

594,922

 

538,278

 

Minority interest

 

 

 

5,430

 

Income (loss) before income tax expense

 

(803,492

)

2,388,937

 

1,497,182

 

Income tax expense

 

620,893

 

810,416

 

1,038,463

 

Net income (loss)

 

$

(1,424,385

)

$

1,578,521

 

$

458,719

 

 

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

Basic

 

$

(0.10

)

$

0.11

 

$

0.04

 

Diluted

 

$

(0.10

)

$

0.10

 

$

0.03

 

 

 

 

 

 

 

 

 

Weighted average shares used in the calculation of net income per common share:

 

 

 

 

 

 

 

Basic

 

14,117,795

 

13,950,457

 

13,033,002

 

Diluted

 

14,117,795

 

15,781,206

 

14,420,810

 

 

4



 

SRS LABS, INC.

CONSOLIDATED BALANCE SHEETS

 

 

 

December 31,
2005

 

December 31,
2004

 

ASSETS

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash and cash equivalents

 

$

8,752,339

 

$

7,011,912

 

Accounts receivable, net of allowance for doubtful accounts of $99,203 in 2005 and $32,962 in 2004

 

2,789,551

 

1,318,665

 

Inventories, net of reserve of $127,007 in 2005 and $240,825 in 2004

 

614,647

 

571,280

 

Prepaid expenses and other current assets, including other receivables of $8,817 in 2005 and $9,004 in 2004

 

944,556

 

1,337,506

 

Deferred income taxes

 

 

23,406

 

Total Current Assets

 

13,101,093

 

10,262,769

 

Investments available for sale

 

17,077,170

 

17,261,267

 

Investment in LLC

 

 

2,596,090

 

Furniture, fixtures and equipment, net

 

1,485,919

 

1,995,579

 

Intangible assets, net

 

2,487,066

 

2,660,955

 

Goodwill

 

533,031

 

533,031

 

Deferred income taxes

 

380,386

 

192,750

 

Total Assets

 

$

35,064,665

 

$

35,502,441

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current Liabilities

 

 

 

 

 

Accounts payable

 

$

1,597,370

 

$

984,805

 

Accrued liabilities

 

2,117,040

 

1,640,714

 

Deferred revenue

 

537,636

 

436,910

 

Income taxes payable

 

 

8,628

 

Total Current Liabilities

 

4,252,046

 

3,071,057

 

Commitments, contingencies and subsequent events

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

Preferred stock—$0.001 par value; 2,000,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock—$0.001 par value; 56,000,000 shares authorized; 14,953,690 and 14,671,416 shares issued; 14,279,592 and 14,229,541 outstanding for 2005 and 2004, respectively

 

14,955

 

14,672

 

Additional paid-in capital

 

63,574,518

 

62,523,292

 

Accumulated other comprehensive loss

 

(496,021

)

(309,722

)

Accumulated deficit

 

(29,277,388

)

(27,853,003

)

Treasury stock at cost 674,098 and 441,875 shares at December 31, 2005 and 2004, respectively

 

(3,003,445

)

(1,943,855

)

Total Stockholders’ Equity

 

30,812,619

 

32,431,384

 

Total Liabilities And Stockholders’ Equity

 

$

35,064,665

 

$

35,502,441

 

 

5